Please login to the form below

Not currently logged in
Email:
Password:

Ziarco

This page shows the latest Ziarco news and features for those working in and with pharma, biotech and healthcare.

Novartis adds oral eczema drug with Ziarco acquisition

Novartis adds oral eczema drug with Ziarco acquisition

Novartis adds oral eczema drug with Ziarco acquisition. Expands dermatology pipeline with first-in-class, Pfizer-developed treatment prospect. ... Novartis has bolstered its dermatology portfolio by buying UK firm Ziarco, bolting on a first-in-class oral

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Ziarco appoints Mike Grey to board of directors Ziarco appoints Mike Grey to board of directors

    Ziarco appoints Mike Grey to board of directors. He is chairman and CEO of Reneo Pharmaceuticals. ... Ed Mathers, chairman of Ziarco, commented: “ We are thrilled to welcome Mike to Ziarco's board of directors.

  • Former Pfizer R&D head LaMattina to advise Ziarco Former Pfizer R&D head LaMattina to advise Ziarco

    Former Pfizer R&D head LaMattina to advise Ziarco. He previously spent 30 years at US pharma firm. ... UK-based biotech Ziarco has hired former head of R&D at Pfizer, Dr John LaMattina, as a strategic R&D adviser.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics